Literature DB >> 18986314

Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma.

Maria Dimopoulou1, Jolle Kirpensteijn, Hester Moens, Marja Kik.   

Abstract

OBJECTIVE: To investigate the histologic characteristics of feline osteosarcoma (OS) and compare the histologic data with phenotypically comparable canine OS. The effects of histologic and clinical variables on survival statistics were evaluated. STUDY
DESIGN: Retrospective study. ANIMALS: Cats (n=62) and dogs (22).
METHODS: Medical records of 62 cats with OS were reviewed for clinically relevant data. Clinical outcome was obtained by telephone interview. Histologic characteristics of OS were classified using a standardized grading system. Histologic characteristics in 22 feline skeletal OS were compared with 22 canine skeletal OS of identical location and subtype. Prognostic variables for clinical outcome were determined using multivariate analysis.
RESULTS: Feline OS was characterized by moderate to abundant cellular pleomorphism, low mitotic index, small to moderate amounts of matrix, high cellularity, and a moderate amount of necrosis. There was no significant difference between histologic variables in feline and canine OS. Histologic grade, surgery, and mitotic index significantly influenced clinical outcome as determined by multivariate analysis. Tumor invasion into vessels was not identified as a significant prognosticator.
CONCLUSION: Feline and canine skeletal OS have similar histologic but different prognostic characteristics. CLINICAL RELEVANCE: Prognosis for cats with OS is related to histologic grade and mitotic index of the tumor.

Entities:  

Mesh:

Year:  2008        PMID: 18986314     DOI: 10.1111/j.1532-950X.2008.00409.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  13 in total

1.  Fracture-associated osteosarcoma of the femur in a cat.

Authors:  Jared I Baum; Owen T Skinner; Sarah E Boston
Journal:  Can Vet J       Date:  2018-10       Impact factor: 1.008

2.  Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.

Authors:  Christiane Gebhard; Andrea Fuchs-Baumgartinger; Ebrahim Razzazi-Fazeli; Ingrid Miller; Ingrid Walter
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

3.  Expression of Snail2 in long bone osteosarcomas correlates with tumour malignancy.

Authors:  Amir-Shaya Sharili; Steve Allen; Ken Smith; Judith Hargreaves; Joanna Price; Imelda McGonnell
Journal:  Tumour Biol       Date:  2011-01-05

4.  Expression of platelet-derived growth factor BB, erythropoietin and erythropoietin receptor in canine and feline osteosarcoma.

Authors:  F R L Meyer; R Steinborn; H Grausgruber; B Wolfesberger; I Walter
Journal:  Vet J       Date:  2015-06-06       Impact factor: 2.688

Review 5.  Animal models and therapeutic molecular targets of cancer: utility and limitations.

Authors:  Maria Cekanova; Kusum Rathore
Journal:  Drug Des Devel Ther       Date:  2014-10-14       Impact factor: 4.162

6.  Late-onset osteosarcoma after onychectomy in a cat.

Authors:  Katrina Breitreiter
Journal:  JFMS Open Rep       Date:  2019-04-09

Review 7.  Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review.

Authors:  Kelly M Makielski; Lauren J Mills; Aaron L Sarver; Michael S Henson; Logan G Spector; Shruthi Naik; Jaime F Modiano
Journal:  Vet Sci       Date:  2019-05-25

8.  Stem cell growth factor receptor in canine vs. feline osteosarcomas.

Authors:  Birgitt Wolfesberger; Andrea Fuchs-Baumgartinger; Juraj Hlavaty; Florian R Meyer; Martin Hofer; Ralf Steinborn; Christiane Gebhard; Ingrid Walter
Journal:  Oncol Lett       Date:  2016-08-12       Impact factor: 2.967

9.  Establishment and Characterization of New Canine and Feline Osteosarcoma Primary Cell Lines.

Authors:  Florian R L Meyer; Ingrid Walter
Journal:  Vet Sci       Date:  2016-06-01

Review 10.  Companion Animals as Models for Inhibition of STAT3 and STAT5.

Authors:  Matthias Kieslinger; Alexander Swoboda; Nina Kramer; Barbara Pratscher; Birgitt Wolfesberger; Iwan A Burgener
Journal:  Cancers (Basel)       Date:  2019-12-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.